Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

“As administrations change, federal agencies’ leadership often changes to align with the incoming president’s priorities,” ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

DetraPel, Inc., a clean-tech advanced materials company, will relocate its headquarters and advanced manufacturing operations ...

The Joint Department of Biomedical Engineering, a collaboration between NC State and UNC-CH, received a $20 million ...

Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Elixirgen Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of rare diseases and aging-associated diseases using its ZSCAN4 technology and mRNA platform ...

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential ...